Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to collect accelerometer data from subjects monitored in an EMU with concurrent video EEG.


Clinical Trial Description

XLTCS (LNE-800) is an international multicenter prospective data collection study to gather accelerometer data. The population under the study comprises patients monitored in an Epilepsy Monitoring Unit (EMU) with concurrent video EEG and who are expected to have at least one seizure with tonic-clonic convulsive movement.

A maximum of one hundred and fifty (150) patients will be enrolled and will wear an accelerometer, and up to 6 sites may participate in this study. The total enrollment period will take approximately 2 years.

Once the accelerometer was adhered to the subject, subjects will be followed for a minimum of 2 days and a maximum of 10 days.

Subject participation will run concurrently with the EMU admission. Exit from the study occurs when the subject's stay in the EMU is completed or the subject is withdrawn or withdraws from the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04282681
Study type Observational
Source LivaNova
Contact
Status Withdrawn
Phase
Start date March 16, 2020
Completion date February 28, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04770337 - Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy N/A
Terminated NCT03831802 - Embrace and Quality of Life N/A
Completed NCT01439438 - Topiramate Bioequivalence Study Brazil - Fast Phase 1
Completed NCT00150787 - Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy. Phase 3
Completed NCT00231556 - A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy Phase 3
Completed NCT03446664 - Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study N/A
Completed NCT00104416 - Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures Phase 3
Completed NCT00043901 - Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug Phase 4
Completed NCT00150813 - Monotherapy With Levetiracetam in Patients Suffering From Epilepsy. Phase 3